Bicara Therapeutics Inc

Research Bicara Therapeutics Inc (BCAX) on Bullrun: market cap USD 1.93B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBCAX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.93B
• Financial periodFY2025
• Net income-USD 137.95M
• Free cash flow-USD 107.11M

Valuation Snapshot

latest market cap is USD 1.93B.

About Bicara Therapeutics Inc

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

Frequently asked questions

What is Bicara Therapeutics Inc's market cap?

Bicara Therapeutics Inc's market capitalization is USD 1.93B.

What does Bicara Therapeutics Inc do?

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.